Vial Announces $67M Series B Led by General Catalyst
Read Vial's feature in the WSJ

Pharmacovigilance

Pharmacovigilance (PV)

Pharmacovigilance (PV) is the process of reviewing and analyzing data of Adverse Events in order review the safety of pharmaceutical products.

Source: